This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Osaka University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Aiko Yahara: Innovator in Antisense Therapies
Introduction
Aiko Yahara is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of molecular biology, particularly in the development of novel molecules for antisense therapies. Her work focuses on creating molecules that can effectively regulate gene expression while being resistant to degradation.
Latest Patents
Aiko Yahara holds a patent for a "Bridged artificial nucleoside and nucleotide." This invention aims to provide a novel molecule for antisense therapies that is not susceptible to nuclease degradation in vivo. The molecule exhibits a high binding affinity and specificity for target mRNAs, allowing for efficient regulation of specific genes. The artificial nucleoside features an amide bond introduced into a bridge structure of 2',4'-BNA/LNA. The oligonucleotide containing this bridged artificial nucleotide demonstrates a binding affinity for single-stranded RNA comparable to known 2',4'-BNA/LNA, while also offering increased nuclease resistance over LNA. This innovation is particularly promising for applications in nucleic acid drugs due to its stronger binding affinity for single-stranded RNAs compared to S-oligo's affinity.
Career Highlights
Aiko Yahara is affiliated with Osaka University, where she continues her research and development in molecular biology. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the realm of gene regulation.
Collaborations
Aiko collaborates with esteemed colleagues such as Yoshiyuki Hari and Satoshi Obika, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Aiko Yahara's contributions to the field of antisense therapies through her innovative patent highlight her role as a leading inventor in molecular biology. Her work not only advances scientific understanding but also paves the way for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
